miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids

Por Bortone, Federica, Scandiffio, Letizia, Marcuzzo, Stefania, Bonanno, Silvia, Frangiamore, Rita, Motta, Teresio, Antozzi, Carlo, Mantegazza, Renato, Cavalcante, Paola, Bernasconi, Pia
Publicado no Front Immunol (2020)

Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study

Por Bonanno, Silvia, Pasanisi, Maria Barbara, Frangiamore, Rita, Maggi, Lorenzo, Antozzi, Carlo, Andreetta, Francesca, Campanella, Angela, Brenna, Greta, Cottini, Lorenzo, Mantegazza, Renato
Publicado no SAGE Open Med (2018)

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Por Clerico, Marinella, De Mercanti, Stefania Federica, Signori, Alessio, Iudicello, Marco, Cordioli, Cinzia, Signoriello, Elisabetta, Lus, Giacomo, Bonavita, Simona, Lavorgna, Luigi, Maniscalco, Giorgia Teresa, Curti, Erica, Lorefice, Lorena, Cocco, Eleonora, Nociti, Viviana, Mirabella, Massimiliano, Baroncini, Damiano, Mataluni, Giorgia, Landi, Doriana, Petruzzo, Martina, Lanzillo, Roberta, Gandoglia, Ilaria, Laroni, Alice, Frangiamore, Rita, Sartori, Arianna, Cavalla, Paola, Costantini, Gianfranco, Sormani, Maria Pia, Capra, Ruggero
Publicado no Neurotherapeutics (2019)